Strengths and weaknesses of FDA-approved/cleared diagnostic devices for the molecular detection of respiratory pathogens

Clinical Infectious Diseases

Volumn 52, Issue SUPPL. 4, 2011, Pages

  Ginocchio, Christine C ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; GOLD NANOPARTICLE; VIRUS RNA;

ARTICLE; BACTERIUM DETECTION; DEVICE APPROVAL; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY CARE; FLUORESCENT ANTIBODY TECHNIQUE; FOOD AND DRUG ADMINISTRATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; MICROORGANISM DETECTION; MOLECULAR DIAGNOSIS; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS IDENTIFICATION;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CROSS INFECTION; DIAGNOSTIC TEST APPROVAL; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; REAGENT KITS, DIAGNOSTIC; RESPIRATORY TRACT INFECTIONS; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79953776430     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir046     Document Type: Article

References (51)

1. Paterson DL. The role ofantimicrobial management programs in op-timizing antibiotic prescribing within hospitals. Clin Infect Dis 2006; 42:S90-5.
2. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005; 18:638-56. (Pubitemid 41504509)
3. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33:757-62. (Pubitemid 32831830)
4. Casiano Colon AE, Hulbert BB, Mayer TK, Walsh EE, Falsey AR. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. J Clin Virol 2003; 28:169-74. (Pubitemid 37040869)
5. Ginocchio CC, Zhang F, Manji R, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45:191-95.
6. Leland D, Ginocchio CC. Role ofcell culture for virus detection in the age oftechnology. Clin Microbiol Rev 2007; 20:49-78. (Pubitemid 46167768)
7. Englund JA, Piedra PA, Jewell A, Patel K, Baxter BB, Whimbey E. Rapid diagnosis of respiratory syncytial virus infections in immunocompro-mised adults.J Clin Microbiol 1996; 34:1649-53. (Pubitemid 26190391)
8. Hall CB, Douglas RG Jr., Geiman JM. Quantitative shedding patterns ofrespiratory syncytial virus in infants.J Infect Dis 1975; 132: 151-6.
9. Henrickson KJ. Diagnostic assays for respiratory syncytial virus. Pe-diatr Infect Dis J 2007; 26:S36-40. (Pubitemid 350295028)
10. Liao RS, Tomalty LL, Majury A, Zoutman DE. Comparison of viral isolation and multiplex real-time reverse transcription-PCR for con-firmation ofrespiratory syncytial virus and influenza virus detection by antigen immunoassays. J Clin Microbiol 2009; 47:527-32.
11. Poehling KA, Edwards KM, Weinberg GA, et al. The unrecognized burden of influenza in young children. N Engl J Med 2006; 355:31-40.
12. Centers for Disease Control and Prevention. Oseltamivirresistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis\North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:969-72.
13. Chan PA, Connell NT, Gabonay AM, et al. Oseltamivir resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised pa-tient. Clin Microbiol Infect 2010; 16:1576-8.
14. Beneri C, Ginocchio CC, Manji R, Sood S. Comparison of clinical features of pediatric RSV and human metapneumovirus infections. Infect Control Hosp Epidemiol 2009; 30:1240-1.
15. Manji R, Lotlikar M, Zhang F, Ginocchio CC. Clinical evaluation of NucliSENS magnetic extraction and NucliSENS analyte specific re-agentsfor the realtime detection of respiratorysyncytial virus (RSV) in paediatric respiratory specimens. J Clin Pathol 2009; 62:998-1002.
16. Hendrickson KJ. Costeffective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections. Pediatr Ann 2005; 34:24-31.
17. Leonardi GP, Leib H, Birkhead GS, Smith C, Costello P, Conron W. Comparison of rapid detection methods for influenza A virus and their value in health care-management ofinstitutionalized geriatric patients. J Clin Microbiol 1994; 32:70-4. (Pubitemid 24016785)
18. Serwint JR, Miller RM. Why diagnose influenza in hospitalized pedi-atric patients? Pediatr Infect Dis J 1993; 12:200-04. (Pubitemid 23101947)
19. Woo PC, Chiu SS, Seto WH, Peiris M. Costeffectiveness of rapid diagnosis ofviral respiratory tract infections in pediatric patients.J Clin Microbiol 1997; 35:1579-81. (Pubitemid 27216837)
20. Bovin G, De Serres G, Hamelin M-E, et al. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 2007; 44:1152-8. (Pubitemid 46651237)
21. Cheng VC, Wu AK, Cheung CH, et al. Outbreak of human meta-pneumovirus infection in psychiatric inpatients: implications for di-rectly observed use of alcohol hand rub in prevention of nosocomial outbreaks. J Hosp Infect 2007; 67:336-43. (Pubitemid 350162968)
22. Centers for Disease Control and Prevention. Outbreak of swineorigin influenza A (H1N1) virus infection\Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:467-70.
23. Centers for Disease Control and Prevention. Swineorigin influenza A (H1N1) virus infections in a school\New York City, May 2009. MMWR Morb Mortal Wkly Rep 2009; 58:470-2.
24. Ginocchio CC, St George K. Likelihood that an unsubtypeable in-fluenza A result in the Luminex xTAG Respiratory Virus Panel is in-dicative ofnovel A/H1N1 (swinelike) influenza.J Clin Microbiol 2009; 47:2347-8.
25. DellaLatta P, Whittier S. Comprehensive evaluation ofperformance, laboratory application, and clinical usefulness of two direct amplifi-cation technologies for the detection of Mycobacterium tuberculosis complex. Am J Clin Pathol 1998; 110:301-10. (Pubitemid 28406987)
26. Guerra RL, Hooper NM, Baker JF, et al. Use of the amplified Myco-bacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care. Chest 2007; 132:946-51.
27. Memish Z. Evaluation and follow up of infectious tuberculosis at the University of Ottawa. Can J Infect Dis 1995; 6:239-43.
28. Centers for Disease Control and Prevention. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009; 58:7-10.
29. Gamboa F, Fernandez G, Padilla E, et al. Comparative evaluation ofinitial and new versions of the GenProbe Amplified Mycobacterium tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in re-spiratoryand nonrespiratoryspecimens.J Clin Microbiol 1998; 36:684-9. (Pubitemid 28093250)
30. Lemâitre N, Armand S, Vachée A, Capilliez O, Dumoulin C, Courcoli RJ. Comparison of the realtime PCR method and the GenProbe Amplified Mycobacterium tuberculosis Direct Test for detection of Mycobacterium tuberculosis in pulmonary and nonpulmonary specimens. J Clin Microbiol 2004; 42:4307-9. (Pubitemid 39296162)
31. O'Sullivan CE, Miller DR, Schneider PS, Roberts GD. Evaluation of GenProbe Amplified Mycobacterium tuberculosis Direct Test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory. J Clin Microbiol 2002; 40:1723-7. (Pubitemid 34493148)
32. Tevere VJ, Hewitt PL, Dare A, et al. Detection of Mycobacterum tu-berculosis by PCR amplification with pan-Mycobacterium primers and hybridization to an M. tuberculosis-specific probe. J Clin Microbiol 1996; 34:918-23.
33. D'Amato RF, Wallman AA, Hochstein LH, et al. Rapid diagnosis of pulmonary tuberculosis by using the Roche AMPLICOR Mycobacte-rium tuberculosis PCR test. J Clin Microbiol 1995; 33:1832-4.
34. Bonington A, Strang JIG, Klapper PE, et al. Use of Roche AMPLICOR Mycobacterum tuberculosis PCR in early diagnosis of tuberculous meningitis. J Clin Microbiol 1998; 36:1251-4. (Pubitemid 28208008)
35. D'Amato RF, Hochstein LH, Colaninno PM, et al. Application of the Roche AMPLICOR Mycobacterum tuberculosis (PCR) test to specimens other than respiratory secretions. Diagn Microbiol Infect Dis 1996; 24:15-7. (Pubitemid 26114853)
36. Van Rie A, Page-Shipp L, Sanne I, Stevens W. Xpert M. tuberculosis/RIF for pointofcare diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diag 2010; 10:937-46.
37. Mahony J, Chong S, Merante F, et al. Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbeadbased assay. J Clin Mi-crobiol 2007; 45:2965-70. (Pubitemid 47417341)
38. Merante F, Yaghoubian S, Janeczko R. Principles of the xTAG respiratory viral panel assay (RVP assay). J Clin Virol 2007; 40: S31-5. (Pubitemid 350298971)
39. xTAG Respiratory Virus Panel [package insert]. Austin, TX, and Toronto, ON, Canada: Luminex Molecular Diagnostics; 2010.
40. Wong S, Pabbaraju K, Lee BE, Fox JD. Enhanced viral etiological diagnosis of respiratory system infection outbreaks by use of a multitarget nucleic acid amplification assay. J Clin Microbiol 2009; 47:3839-45.
41. ProFlu+ Assay [packageinsert]. San Diego, CA, andWaukesha, WI: Gen-Probe/Prodesse; 2010.
42. LeGoff J, Kara R, Moulin F, et al. Evaluation of the onestep multiplex realtime reverse transcription-PCR ProFlu1 assay for detection of influenza A and influenza B viruses and respiratory syncytial viruses in children. J Clin Microbiol 2008; 46:789-91. (Pubitemid 351231339)
43. ProFluST Assay [package insert]. San Diego, CA, and Waukesha, WI: Gen-Probe/Prodesse; 2009.
44. Pro hMPV+ Assay [package insert]. San Diego, CA, and Waukesha, WI: Gen-Probe/Prodesse; 2010.
45. ProParaflu+ Assay [package insert]. San Diego, CA, andWaukesha, WI: Gen-Probe/Prodesse; 2010.
46. Verigene Respiratory Virus Nucleic Acid Test [package insert]. Northbrook, IL: Nanosphere; 2010.
47. VRNATsp [package insert]. Northbrook, IL: Nanosphere; 2010.
48. Storhoff JJ, Lucas AD, Viswanadham G, Bao YP, Müller UR. Homo-geneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes. Nat Biotechnol 2004; 22:883-7. (Pubitemid 38886609)
49. Ginocchio CC. Quality assurance in clinical virology. In Specter S, Hodinka R, Young SA, Wiedbrauk DL eds. Clinical Virology Manual. 4th ed. Washington, DC: ASM Press, 2009; 3-17.
50. Crawford JM, Stallone R, Zhang F, et al. Laboratory surge response to pandemic (H1N1) 2009 outbreak, New York City metropolitan area, USA. Emerg Infect Dis 2010; 16:8-13.
51. McAdam AJ. Discrepant analysis: how can we test a test? J Clin Mi-crobiol 2000; 38:2027-9. (Pubitemid 30414310)